The Obama administration took the easy political path on embryonic stem cells last week by proposing to pay for research only on stem cell lines created from surplus embryos at fertility clinics but not on lines created in the laboratory to study particular diseases.
The proposal is not bold enough and will continue to deny federal financing to some potentially promising research. Still it is a significant improvement over former President George W. Bush’s rules that allowed federal support for work with only 21 stem cell lines already created from surplus embryos at fertility clinics.
http://www.nytimes.com/2009/04/23/opinion/23thu2.html?_r=1
No comments:
Post a Comment